Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-14
1998-12-29
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424443, 424444, 424449, A61K 31415, A61K 970, A61L 1516
Patent
active
058542710
ABSTRACT:
The administration of histidine is able to prevent and ameliorate tissue and cellular damage which is caused by damaging levels of cytokines and growth factors. It is shown that histidine, when administered in therapeutic quantities is able to inhibit cytokines and growth factors involved in cell and tissue damage. In addition, the method of administering histidine to inhibit these molecules can prevent and ameliorate tissue, vessel and cell damage from restenosis, burns, surgical procedures and other disorders which cause and result from damaged tissues, vessels and cells.
REFERENCES:
patent: 4734276 (1988-03-01), Ziegler
patent: 5280038 (1994-01-01), Kukreja et al.
Eugui et al., "Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-.alpha., IL-.beta., and IL-6 by human peripheral blood mononuclear cells," Int'l Immunol. 6(3):409-422 (1993).
Gebhard et al., "Bretschneider's Histidine-Buffered Cardioplegic Solution: Concept, Application, and Efficiency," Myocardial Protection in Cardiac Surgery, pp. 95-119 (1987).
Grimble, "Malnutrition and the immune response 2. Impact of nutrients on cytokine biology in infection," Transactions of the Royal Society of Tropical Medicine and Hygiene 88:615-619 (1994).
Grimble, "Nutritional Antioxidants and the Modulation of Inflammation: Theory and Practice," New Horizons 2(2):175-185 (1994).
Kelly et al., "Dimethyl Sulfoxide Modulates NF-.kappa.B and Cytokine Activation in Lipopolysaccharide-Treated Murine Macrophages," Infect. Immun. 62(8):3122-3128 (1994).
Shenkar et al., "Effects of treatment with the 21-aminosteroid, U74389F, on pulmonary cytokine expression following hemorrhage and resuscitation," Critical Care Medicine 23(1):132-139 (1995).
Askanazi et al., "Muscle and Plasma Amino Acids Following Injury," Annl. Surg. 192(1):78-85 (1980).
Maldonado et al., "Specific Serum Amino-acid Profiles of Trauma and Septic Children," Clin. Nutr. 7(3):165-170 (1988).
J.S. Solomkin, M.D.; "Neutrophil Disorders in Burn Injury: Complement, Cytokines, and Organ Injury"; The Journal of Trauma, vol. 30, No. 12 Supp., Dec. 1990, pp. S80-S84.
P. Libby et al.; "A Cascade Model for Restenosis"; Circulation, Supp. III, vol. 8, No. 6, Dec. 1992; pp. III-47--III-52.
M. Sasaki et al.; "Role of Calpains and Kininogens in Inflammation"; Acts Biologica Hungerica 42(1-3), pp. 231-241 (1991).
W. Konig et al.; "Microbial Pathogenicity and Host Defense in Burned Patients: the Role of Inflammatory Mediators"; Infection 20 (1992) Suppl. 2; p. S128.
J.J. Oppenheim et al.; "Clinical Applications of Cytokines"; Oxford University Press (1993); pp. 3-15 and 35-42.
M.S. Cohen; "Molecular Events in the Activation of Human Neutrophils for Microbial Killing"; Clinical Infectious Diseases 1994;18(Suppl 2); pp. S170-S179.
D.C. Dale; "Potential Role of Colony-Stimulating Factores in the Prevention and Treatment of Infectious Diseases"; Clinical Infectious Diseases 1994;18 (Suppl 2); pp. S180-S188.
J. Crawford et al.;"Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia . . . Cancer"; Clinical Infectious Diseases 1994;18(Suppl 2); S189-196.
S. Nelson; "Role of Granulocyte Colony-Stimulating Factor in the Immune Response . . . An Overview"; Clinical Infectious Diseases 1994;18 (Suppl 2); pp. S197-S204.
M.P. Glauser et al.; "Pathogenesis and Potential Strategies for Prevention and Treatment of Septic Shock: an Update"; Clinical Infectious Diseases 1994;18 (Suppl 2); pp. S206-S216.
Diaz Jose-Luis
Thomas Peter G.
Angres Isaac A.
Cytos Pharmaceuticals, L.L.C.
Jarvis William R. A.
Petraglia Susan P.
LandOfFree
Effective method for the amelioration and prevention of tissue a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Effective method for the amelioration and prevention of tissue a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Effective method for the amelioration and prevention of tissue a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1425189